Immitra Bio Logo Immitra Bio
TURNING BLOOD STEM CELLS INTO LIVING DRUGS

000+

Rare diseases

0M+

Patients worldwide

0%

Lack approved therapies

0%

Are children

Unlocking the Potential of Genetic Cures

At Immitra Bio, we are pioneering a novel genetic medicine platform by combining two of the most powerful biomedical technologies: Hematopoietic Stem Cells (HSCs) and CRISPR-Cas9 gene editing. Our innovative approach enables precise and durable gene modifications within blood stem cells, unlocking transformative treatments for rare diseases with high unmet medical needs.

Meet Our Team

CEO

Jan Nelis

CEO and co-founder

LinkedIn
CSO

Amir Taheri

CSO and co-Founder

LinkedIn
Advisor

Prof. Jacob Corn

Co-founder and Scientific Advisor

LinkedIn

Our Sponsors & Partners

© 2025 Immitra Bio. All Rights Reserved.
LinkedIn

Privacy Policy

At Immitra Bio GmbH, we value your privacy. This Privacy Policy explains how we handle any personal information when you visit our website.

  • No Data Collection: We do not collect any personal information from our website visitors. We do not require you to provide any personal details to access or use the website.
  • No Third-Party Services: We do not use any third-party services, such as analytics tools, advertising, or other embedded content, that might collect or track your data.
  • Cookies: Our website may use cookies for basic functionality, such as ensuring the proper operation of the website. These cookies do not collect any personal information.
  • Changes to this Policy: We may update this Privacy Policy from time to time. Any changes will be posted on this page, and the updated policy will be effective as of the date it is posted.

If you have any questions about this Privacy Policy, feel free to contact us at info@immitrabio.com.